Rufinamide
- Generic Name
- Rufinamide
- Brand Names
- Banzel, Inovelon
- Drug Type
- Small Molecule
- Chemical Formula
- C10H8F2N4O
- CAS Number
- 106308-44-5
- Unique Ingredient Identifier
- WFW942PR79
- Background
Rufinamide is a triazole derivative and an anticonvulsant medication to treat seizure disorders like Lennox-Gastuat syndrome, a form of childhood epilepsy. Clinical trials suggest its efficacy in the treatment of partial seizures.
- Indication
治疗4岁以上及成人Lennox-Gastaut症候群的癫痫症。
- Associated Conditions
- Lennox-Gastaut Syndrome
- Associated Therapies
- -
Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures
- First Posted Date
- 2006-06-08
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 356
- Registration Number
- NCT00334958
- Locations
- 🇺🇸
University of South Alabama Medical Center, Mobile, Alabama, United States
🇺🇸Bradenton Research Center, Bradenton, Florida, United States
🇺🇸Advocate Hope Children's Hospital, Oak Lawn, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath